Hui-Wen Lo

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Venues

Oncogene

NPJ breast cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel L Doheny, Sherona Sirkisoon, Richard L Carpenter, Noah Reeve Aguayo, Angelina T Regua, Marlyn Anguelov, Sara G Manore, Austin Arrigo, Sara Abu Jalboush, Grace L Wong, Yang Yu, Calvin J Wagner, Michael Chan, Jimmy Ruiz, Alexandra Thomas, Roy Strowd, Jiayuh Lin, Hui-Wen Lo
Correction: Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis. Oncogene (2024)
Kojo Agyemang, Allan M Johansen, Grayson W Barker, Michael J Pennison, Kimberly Sheffield, Hugo Jimenez, Carl Blackman, Sambad Sharma, Patrick A Fordjour, Ravi Singh, Katherine Loree Cook, Hui-Kuan Lin, Wei Zhang, Hui-Wen Lo, Kounosuke Watabe, Peiqing Sun, Carl D Langefeld, Boris C Pasche
TGFBR1*6A as a modifier of breast cancer risk and progression: advances and future prospects. NPJ breast cancer 8 (1) (2022)
Daniel L Doheny, Sherona Sirkisoon, Richard L Carpenter, Noah Reeve Aguayo, Angelina T Regua, Marlyn Anguelov, Sara G Manore, Austin Arrigo, Sara Abu Jalboush, Grace L Wong, Yang Yu, Calvin J Wagner, Michael Chan, Jimmy Ruiz, Alexandra Thomas, Roy Strowd, Jiayuh Lin, Hui-Wen Lo
Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis. Oncogene 39 (42) (2020)
Guanwen Wang, Juan Wang, Antao Chang, Dongmei Cheng, Shan Huang, Dan Wu, Sherona Sirkisoon, Shuang Yang, Hui-Kuan Lin, Hui-Wen Lo, Rong Xiang, Peiqing Sun
Her2 promotes early dissemination of breast cancer by suppressing the p38 pathway through Skp2-mediated proteasomal degradation of Tpl2. Oncogene 39 (47) (2020)

Hui-Wen Lo.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hui-Wen Lo